BeOne Medicines (ONC) Net Margin (QoQ) (2015 - 2026)

BeOne Medicines (ONC) Net Margin (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1,058.00
Dec 31, 2025 -440.00
Sep 30, 2025 167.00
Jun 30, 2025 706.00
Mar 31, 2025 1,358.00
Dec 31, 2024 -135.00
Sep 30, 2024 84.00
Jun 30, 2024 2,045.00
Mar 31, 2024 2,452.00
Dec 31, 2023 -8,551.00
Sep 30, 2023 9,160.00
Jun 30, 2023 1,378.00
Mar 31, 2023 3,935.00
Dec 31, 2022 2,667.00
Sep 30, 2022 2,179.00
Jun 30, 2022 -2,369.00
Mar 31, 2022 13,411.00
Dec 31, 2021 -6,382.00
Sep 30, 2021 10,802.00
Jun 30, 2021 -33,122.00